General Information of Drug Off-Target (DOT) (ID: OT4U88UP)

DOT Name Max dimerization protein 3 (MXD3)
Synonyms Max dimerizer 3; Class C basic helix-loop-helix protein 13; bHLHc13; Max-associated protein 3; Max-interacting transcriptional repressor MAD3; Myx
Gene Name MXD3
Related Disease
Cerebellar neoplasm ( )
Acute lymphocytic leukaemia ( )
Adult glioblastoma ( )
Advanced cancer ( )
Brain neoplasm ( )
Cardiovascular disease ( )
Craniosynostosis ( )
Glioblastoma multiforme ( )
Neuroblastoma ( )
Medulloblastoma ( )
UniProt ID
MAD3_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF00010
Sequence
MEPLASNIQVLLQAAEFLERREREAEHGYASLCPHRSPGPIHRRKKRPPQAPGAQDSGRS
VHNELEKRRRAQLKRCLERLKQQMPLGADCARYTTLSLLRRARMHIQKLEDQEQRARQLK
ERLRSKQQSLQRQLEQLRGLAGAAERERLRADSLDSSGLSSERSDSDQEELEVDVESLVF
GGEAELLRGFVAGQEHSYSHGGGAWL
Function
Transcriptional repressor. Binds with MAX to form a sequence-specific DNA-binding protein complex which recognizes the core sequence 5'-CAC[GA]TG-3'. Antagonizes MYC transcriptional activity by competing for MAX and suppresses MYC dependent cell transformation.

Molecular Interaction Atlas (MIA) of This DOT

10 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Cerebellar neoplasm DIS859E0 Definitive Altered Expression [1]
Acute lymphocytic leukaemia DISPX75S Strong Biomarker [2]
Adult glioblastoma DISVP4LU Strong Altered Expression [3]
Advanced cancer DISAT1Z9 Strong Biomarker [3]
Brain neoplasm DISY3EKS Strong Altered Expression [4]
Cardiovascular disease DIS2IQDX Strong Genetic Variation [5]
Craniosynostosis DIS6J405 Strong Altered Expression [6]
Glioblastoma multiforme DISK8246 Strong Altered Expression [3]
Neuroblastoma DISVZBI4 Strong Altered Expression [7]
Medulloblastoma DISZD2ZL Limited Altered Expression [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
11 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the expression of Max dimerization protein 3 (MXD3). [8]
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Max dimerization protein 3 (MXD3). [9]
Tretinoin DM49DUI Approved Tretinoin decreases the expression of Max dimerization protein 3 (MXD3). [10]
Estradiol DMUNTE3 Approved Estradiol decreases the expression of Max dimerization protein 3 (MXD3). [11]
Arsenic DMTL2Y1 Approved Arsenic affects the expression of Max dimerization protein 3 (MXD3). [12]
Calcitriol DM8ZVJ7 Approved Calcitriol decreases the expression of Max dimerization protein 3 (MXD3). [13]
Testosterone DM7HUNW Approved Testosterone decreases the expression of Max dimerization protein 3 (MXD3). [13]
Troglitazone DM3VFPD Approved Troglitazone decreases the expression of Max dimerization protein 3 (MXD3). [14]
Cytarabine DMZD5QR Approved Cytarabine increases the expression of Max dimerization protein 3 (MXD3). [15]
Curcumin DMQPH29 Phase 3 Curcumin decreases the expression of Max dimerization protein 3 (MXD3). [16]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 decreases the expression of Max dimerization protein 3 (MXD3). [18]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Max dimerization protein 3 (MXD3). [17]
------------------------------------------------------------------------------------

References

1 A novel role of the Mad family member Mad3 in cerebellar granule neuron precursor proliferation.Mol Cell Biol. 2007 Dec;27(23):8178-89. doi: 10.1128/MCB.00656-06. Epub 2007 Sep 24.
2 Targeted therapy with MXD3 siRNA, anti-CD22 antibody and nanoparticles for precursor B-cell acute lymphoblastic leukaemia.Br J Haematol. 2014 Nov;167(4):487-99. doi: 10.1111/bjh.13066. Epub 2014 Sep 8.
3 Alternative Splicing of MXD3 and Its Regulation of MXD3 Levels in Glioblastoma.Front Mol Biosci. 2019 Feb 19;6:5. doi: 10.3389/fmolb.2019.00005. eCollection 2019.
4 From cerebellar proliferation to tumorigenesis: new insights into the role of Mad3.Cell Cycle. 2008 Feb 15;7(4):423-7. doi: 10.4161/cc.7.4.5413. Epub 2007 Dec 6.
5 Leveraging Polygenic Functional Enrichment to Improve GWAS Power.Am J Hum Genet. 2019 Jan 3;104(1):65-75. doi: 10.1016/j.ajhg.2018.11.008. Epub 2018 Dec 27.
6 Combined therapy with melatonin and exendin-4 effectively attenuated the deterioration of renal function in rat cardiorenal syndrome.Am J Transl Res. 2017 Feb 15;9(2):214-229. eCollection 2017.
7 MXD3 antisense oligonucleotide with superparamagnetic iron oxide nanoparticles: A new targeted approach for neuroblastoma.Nanomedicine. 2020 Feb;24:102127. doi: 10.1016/j.nano.2019.102127. Epub 2019 Nov 26.
8 Effects of lithium and valproic acid on gene expression and phenotypic markers in an NT2 neurosphere model of neural development. PLoS One. 2013;8(3):e58822.
9 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
10 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
11 Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012 Nov;22(11):2153-62.
12 Drinking-water arsenic exposure modulates gene expression in human lymphocytes from a U.S. population. Environ Health Perspect. 2008 Apr;116(4):524-31. doi: 10.1289/ehp.10861.
13 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
14 Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells. World J Gastroenterol. 2009 Jan 21;15(3):310-20.
15 Cytosine arabinoside induces ectoderm and inhibits mesoderm expression in human embryonic stem cells during multilineage differentiation. Br J Pharmacol. 2011 Apr;162(8):1743-56.
16 Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic effect of curcumin. Mol Cancer Ther. 2005 Feb;4(2):233-41.
17 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
18 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.